Meningioma News and Research

RSS

Long term use of desogestrel linked to small increase in brain tumor risk

Taking the progestogen-only contraceptive pill desogestrel continuously for more than five years is associated with a small increased risk of developing a type of brain tumor called an intracranial meningioma, finds a study from France published by The BMJ today.

12 Jun 2025

GLP-1RAs show added protection against cancer beyond weight reduction

New research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal eClinicalMedicine finds that first generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss.

11 May 2025

Study evaluates long-term outcomes of gamma knife radiosurgery in patients with grade 2 meningiomas

The role of radiosurgery in the treatment of grade 2 meningioma remains unclear. This study aimed to evaluate the long-term outcomes of gamma knife radiosurgery (GKRS) in patients with grade 2 meningiomas and to identify factors influencing tumor control and survival.

28 Apr 2025

Waist circumference identified as a stronger cancer risk marker in men

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) and published in The Journal of the National Cancer Institute shows that waist circumference (WC) is a stronger risk marker than BMI for developing obesity-related cancers in men, but not women.

24 Mar 2025

New biomarker can accurately predict outcomes in meningiomas and breast cancers

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

13 Feb 2025

Study explores cancer risks of hormonal contraceptives

Many women worry hormonal contraceptives have dangerous side-effects including increased cancer risk. But this perception is often out of proportion with the actual risks.

15 Jan 2025

Plymouth researchers lead initiative to advance the study of meningiomas in NF2-SWN

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN).

18 Dec 2024

CheekAge: Next-gen epigenetic clock accurately predicts mortality risk

Researchers developed CheekAge, an epigenetic clock based on buccal cells, and found it predicted mortality risk with significant accuracy. This study validates CheekAge as a reliable aging biomarker, outperforming first-generation clocks.

6 Oct 2024

Diagnostic performance of GPT-4 in analyzing radiology findings from brain tumors

GPT-4 demonstrates diagnostic capabilities in brain radiology, achieving 73% accuracy for final diagnoses and 94% for differential diagnoses in recent research.

3 Oct 2024

Extending survival in meningioma patients with innovative radiopharmaceutical therapy

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, a type of brain tumor.

29 Sep 2024

Excess body weight at first cancer diagnosis increases risk of second cancer

Adults with excess body weight at their first cancer diagnosis face a higher risk of developing a second primary cancer, particularly those related to obesity, according to a recent study. The research emphasizes the need for survivorship guidelines targeting weight management.

22 Sep 2024

Blood cancer drug could help improve the efficiency of radiotherapy in meningiomas

Drugs developed to fight blood and other cancers could also help improve the efficiency of radiotherapy in the most commonly diagnosed low-grade brain tumour in adults, a new study has found.

10 Jul 2024

Scientists identify over 5,000 genetic variants that enable certain cancers to thrive

Researchers performed saturation genome editing of the BAP1, whose dysfunction is related to cancer and impaired neurodevelopment.

10 Jul 2024

GLP-1 drugs found to lower cancer risk in diabetes patients

Research finds that GLP-1 receptor agonists significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetes patients compared to insulins, but show varied results against metformin.

8 Jul 2024

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Drugs developed to combat HIV and AIDS are being trialed for the first time in patients with multiple brain tumors.

21 Jun 2024

Questions about childhood weight can help identify increased mortality risk in adults with obesity

Being asked whether you considered yourself a normal weight, plumper or thinner as a child when attending a doctor's appointment as an adult might appear like a very strange question to ask, but new research being presented at this year's European Congress on Obesity in Venice, Italy (12-15 May) suggests that such questions can help identify increased mortality risk in adults living with obesity.

13 May 2024

Meningioma News and Research

Long term use of desogestrel linked to small increase in brain tumor risk

GLP-1RAs show added protection against cancer beyond weight reduction

Study evaluates long-term outcomes of gamma knife radiosurgery in patients with grade 2 meningiomas

Waist circumference identified as a stronger cancer risk marker in men

New biomarker can accurately predict outcomes in meningiomas and breast cancers

Study explores cancer risks of hormonal contraceptives

Plymouth researchers lead initiative to advance the study of meningiomas in NF2-SWN

CheekAge: Next-gen epigenetic clock accurately predicts mortality risk

Diagnostic performance of GPT-4 in analyzing radiology findings from brain tumors

Extending survival in meningioma patients with innovative radiopharmaceutical therapy

Excess body weight at first cancer diagnosis increases risk of second cancer

Blood cancer drug could help improve the efficiency of radiotherapy in meningiomas

Scientists identify over 5,000 genetic variants that enable certain cancers to thrive

GLP-1 drugs found to lower cancer risk in diabetes patients

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Questions about childhood weight can help identify increased mortality risk in adults with obesity

Certain progestogens linked to higher brain tumor risk in women, study suggests

Researchers identify increased brain tumor risk with specific contraceptive use

Long-term use of certain progestogen drugs may raise risk of intracranial meningioma

New advance in the development of a test for early diagnosis of cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News